• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICBLE
Device Problems Leak/Splash (1354); Device Displays Incorrect Message (2591)
Patient Problems Virus (2136); No Known Impact Or Consequence To Patient (2692)
Event Date 03/11/2020
Event Type  malfunction  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the reportable malfunction of the pressure dome membrane leak.Since this malfunction is only associated with the kit, this mdr will be against the kit.A batch record review for kit lot h134 was conducted.There were no non-conformances associated with this lot.This lot met all release requirements.A review of kit lot h134 shows no trends.Trends were reviewed for complaint categories, alarm #18: system pressure, alarm #19: fluid balance limit, and pressure dome membrane leak.No trends were detected for these complaint categories.The assessment is based on the information available at the time of investigation.No product was returned for investigation; therefore, it could not be determined if the product met specification based solely on the information provided by the customer.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Investigation complete (b)(4).
 
Event Description
The distributor emailed to report a pressure dome membrane leak that occurred with a cellex photopheresis kit ("kit") during an extracorporeal photopheresis (ecp) treatment procedure.The distributor stated that an alarm 18: system pressure alarm occurred near the end of the patient's ecp treatment procedure.The distributor reported that the customer then noticed a leak at the system pressure dome.The distributor stated that an alarm #19: fluid balance limit alarm occurred after the alarm #18: system pressure alarm.The distributor reported that the patient's fluid balance was positive.The distributor stated that the patient's ecp treatment was completed with both blood and uvadex treated cells returned to the patient.The distributor reported that all of the patient's scheduled ecp treatment procedures have been canceled due to the covid 19 situation.Although requested, no product was returned for investigation.
 
Manufacturer Narrative
The smart card was returned for evaluation.Based on the smart card data the kit lot number involved in this case was kit lot h140.Corrected: d4 and h4.A batch record review for kit lot h140 was conducted.There were no non-conformances associated with this lot.This lot met all release requirements.A review of kit lot h140 shows no trends.The smart card data was reviewed.Prime was completed without incident and blood collection began.Two alarm #18: system pressure alarms then occurred due to pressure at -9 mm hg after 109 ml and 164 ml of whole blood processed.Following the second alarm #18: system pressure alarm, an alarm #4: centrifuge chamber door alarm occurred and the customer opened and then closed the centrifuge door.The treatment continued as expected with the completion of the buffy collection and photoactivation.The uvadex treated cells were also fully reinfused to the patient.An alarm #53: return line air detected alarm occurred during the reinfusion of the remaining fluid within the return bag.Several alarm #19: fluid balance alarms then occurred as the patient's fluid balance (501 ml) was over the device's preset fluid balance limits of + / - 500 ml.The customer then powered off the device.The smart card review confirmed the reported alarm #18: system pressure and alarm #19: fluid balance alarms; however, the root cause for these alarms could not be determined based on the available information.The smart card investigation could not confirm the occurrence of a pressure dome membrane leak.No further action is required at this time.The investigation is complete.(b)(4).S.K.6/25/2020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS
bedminster NJ
MDR Report Key9943930
MDR Text Key198757733
Report Number2523595-2020-00052
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Type of Report Initial,Followup
Report Date 06/25/2020
1 Device was Involved in the Event
2 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/01/2021
Device Model NumberNOT APPLICBLE
Device Catalogue NumberCLXECP
Device Lot NumberH140
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/13/2020
Initial Date FDA Received04/09/2020
Supplement Dates Manufacturer Received05/27/2020
Supplement Dates FDA Received06/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number0
-
-